Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Post Reporter.
Press releases published on May 22, 2025
Abcourt Announces its Results for the Third Quarter Ended March 31, 2025
GlobeNewswire
·
May 22, 2025
ROUYN-NORANDA, Quebec, May 22, 2025 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) announces its results for the third quarter ended March 31, 2025. All monetary values in this press release are …
IMUNON Announces Withdrawal of Form S-1 Registration Statement
GlobeNewswire
·
May 22, 2025
LAWRENCEVILLE, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has filed a request for withdrawal with the Securities and …
Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel
GlobeNewswire
·
May 22, 2025
SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …
Daktronics to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28th
GlobeNewswire
·
May 22, 2025
BROOKINGS, S.D., May 22, 2025 (GLOBE NEWSWIRE) -- Daktronics, Inc. (Nasdaq: DAKT), a leading global designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide today announced that Brad …
ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025
GlobeNewswire
·
May 22, 2025
ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025 ICT01 in combination with azacitidine and venetoclax (Aza-Ven) achieves unprecedented high remission rates overall and across molecular subtypes in newly …
Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
GlobeNewswire
·
May 22, 2025
CAMBRIDGE, Mass. and TOKYO, Japan and PRINCETON, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), Taiho Pharmaceutical Co., Ltd., and Taiho Oncology, Inc. today announced new positive results from the pivotal Phase 2b …
Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
GlobeNewswire
·
May 22, 2025
Preliminary efficacy analysis from the elacestrant plus everolimus and ribociclib cohorts of the ELEVATE study, along with updated safety data from additional cohorts of elacestrant plus targeted therapy combination arms, will be presented. These data …
Chinese technology deal speeds up Pakistan's pharma production
EIN Presswire
·
May 22, 2025
SHEIKHUPURA, PAKISTAN, May 22, 2025 /EINPresswire.com/ -- Pharmaceutical machinery provider Xin Weisheng is streamlining Pakistan’s manufacturing of healthcare products with its unique processing equipment. Xin Weisheng technology is enabling …
Lynch Carpenter Investigates Claims in Marlboro-Chesterfield Pathology Data Breach
GlobeNewswire
·
May 22, 2025
PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Marlboro-Chesterfield Pathology (“MCP”) recently announced a cybersecurity incident, which impacted the personal information of thousands of individuals. The information potentially impacted in the data breach …
Actuate Therapeutics Announces Details for 2025 ASCO Annual Meeting Presentation on Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
GlobeNewswire
·
May 22, 2025
Phase 2 (Actuate-1801 Part 3B) trial topline results meet primary endpoint of improved survival in previously untreated patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) Oral presentation at the American Society of Clinical Oncology (ASCO) …
Avidicure to Present Preclinical Data from Lead TROP2-targeting Multifunctional Antibody Program at the 2025 American Society of Clinical Oncology Annual Meeting
GlobeNewswire
·
May 22, 2025
AMSTERDAM, May 22, 2025 (GLOBE NEWSWIRE) -- Avidicure, a biotechnology company pioneering an entirely new dual agonistic, multifunctional antibody modality with broad applicability in oncology, today announced its upcoming presentation at the 2025 American …
Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
GlobeNewswire
·
May 22, 2025
NEEDHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Lyme Timber Receives the 2025 SFI Leadership in Conservation Award for Advancing Nature-Based Solutions in SFI-Certified Forests
GlobeNewswire
·
May 22, 2025
MINNEAPOLIS, May 22, 2025 (GLOBE NEWSWIRE) -- The Sustainable Forestry Initiative (SFI) is pleased to announce The Lyme Timber Company as the recipient of the 2025 SFI Leadership in Conservation Award. Lyme Timber, certified to the SFI Forest Management …
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
GlobeNewswire
·
May 22, 2025
LOUISVILLE, Colo., May 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that new data will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, …
SABIO DISRUPT LONDON 2025: CX LEADERS SHOWCASE AI INNOVATION AND TRANSFORMATION SUCCESS
EIN Presswire
·
May 22, 2025
Industry giants in CX converged on London this week for Disrupt 2025, the latest leg in Europe's premier digital transformation and innovation programme LONDON, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- Industry giants in customer experience ( …
ImPact Biotech Announces Late-Breaking Podium Presentation at ASCO 2025 Highlighting ENLIGHTED Study Interim Analysis
GlobeNewswire
·
May 22, 2025
-- Company to present interim update from ENLIGHTED Phase 3 Study in LG UTUC following assessment of 50% of targeted total evaluable patient enrollment -- TEL AVIV, Israel, May 22, 2025 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology …
Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma
GlobeNewswire
·
May 22, 2025
First results to be presented in two ASCO oral presentations Data in both combinations demonstrate high response rates TARRYTOWN, N.Y., May 22, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced initial results from two …
VCI Global Revises Equity Agreement with 102% Premium Pricing, Enhancing Strategic Flexibility
GlobeNewswire
·
May 22, 2025
KUALA LUMPUR, Malaysia, May 22, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”), a diversified global holding company with a strategic focus on AI …
NVIDIA Stock Strengthens Amid Robust AI Growth and Strategic Initiatives
EIN Presswire
·
May 22, 2025
Investors optimistic as NVIDIA stock price recovers on strong earnings and AI market expansion SANTA CLARA, CA, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- NVIDIA Corporation (NASDAQ: NVDA), a global leader in accelerated computing and artificial …
MetaCode M and HKU Host Global AI/Data Forum to Launch Borderless Career Programs
EIN Presswire
·
May 22, 2025
From university partnerships to global bootcamps, MetaCode M is redefining career education for the next generation of AI and data professionals. NEW YORK, NY, UNITED STATES, May 21, 2025 /EINPresswire.com/ -- [HKU DSA X MetaCode – Global AI∙Data Trend …